Jundishapur Journal of Microbiology

Published by: Kowsar

Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma

Kamyar Makvandi 1 , Nastaran Ranjbari 2 , * , Manoochehr Makvandi 3 , Ali Ashraf Teimori 3 , Niloofar Neisi 3 , Mojtaba Rasti 1 , Vida Alipour 1 , Mostafa Albokord 1 , Malek Kanani 2 , Ramezan Ahadi 4 and Ala Habibian 3
Authors Information
1 Infectious and Tropical Disease Research Center, Health Research Institute, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pathology, Imam Khomeini hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Department of Nuclear Medicine, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: November 01, 2015, 8 (11); e25726
  • Published Online: November 21, 2015
  • Article Type: Research Article
  • Received: December 10, 2014
  • Revised: April 5, 2015
  • Accepted: May 23, 2015
  • DOI: 10.5812/jjm.25726

To Cite: Makvandi K, Ranjbari N, Makvandi M, Ashraf Teimori A, Neisi N, et al. Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma, Jundishapur J Microbiol. 2015 ; 8(11):e25726. doi: 10.5812/jjm.25726.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood. 2011; 117(6): 1792-8[DOI][PubMed]
  • 2. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009; 49(5 Suppl)-55[DOI][PubMed]
  • 3. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet. 1999; 353(9160): 1253-7[DOI]
  • 4. Rossner MT. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol. 1992; 36(2): 101-17[PubMed]
  • 5. Khaled IAA, Mahmoud OM, Saleh AF, Baioumi EA. Prevalence of HBV genotypes in Egypt among hepatitis patients. J Am Sci. 2010; 6(11): 185-90
  • 6. Couroucé-Pauty AM, Plançon A, Soulier JP. Distribution of HBsAg Subtypes in the World. Vox Sanguinis. 1983; 44(4): 197-211[DOI]
  • 7. Bouffard P, Lamelin JP, Zoulim F, Lepot D, Trepo C. Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection. J Med Virol. 1992; 37(4): 255-62[PubMed]
  • 8. Calmus Y, Marcellin P, Beaurain G, Chatenoud L, Brechot C. Distribution of hepatitis B virus DNA sequences in different peripheral blood mononuclear cell subsets in HBs antigen-positive and negative patients. Eur J Clin Invest. 1994; 24(8): 548-52[PubMed]
  • 9. Malave Lara C, Gorrino MT, Campelo C, Lardelli P, Cisterna R. Detection of hepatitis B virus DNA and determination of surface antigen expression in peripheral blood mononuclear cells from patients with AIDS. Eur J Clin Microbiol Infect Dis. 1994; 13(3): 267-71[PubMed]
  • 10. Yoffe B, Noonan CA, Melnick JL, Hollinger FB. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis. 1986; 153(3): 471-7[PubMed]
  • 11. Baginski I, Chemin I, Bouffard P, Hantz O, Trepo C. Detection of polyadenylated RNA in hepatitis B virus-infected peripheral blood mononuclear cells by polymerase chain reaction. J Infect Dis. 1991; 163(5): 996-1000[PubMed]
  • 12. Roisman FR, Castello A, Fainboim H, Morelli A, Fainboim L. Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol. 1994; 70(2): 99-103[PubMed]
  • 13. Stoll-Becker S, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol. 1997; 71(7): 5399-407[PubMed]
  • 14. Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation. 1990; 49(6): 1155-8[PubMed]
  • 15. Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley A, et al. Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology. 1992; 16(1): 36-41[PubMed]
  • 16. Pontisso P, Vidalino L, Quarta S, Gatta A. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev. 2008; 8(1): 13-7[DOI][PubMed]
  • 17. Murakami Y, Minami M, Daimon Y, Okanoue T. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J Med Virol. 2004; 72(2): 203-14[DOI][PubMed]
  • 18. Umeda M, Marusawa H, Seno H, Katsurada A, Nabeshima M, Egawa H, et al. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J Hepatol. 2005; 42(6): 806-12[DOI][PubMed]
  • 19. Pontisso P, Poon MC, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in mononuclear blood cells. BMJ. 1984; 288(6430): 1563-6[DOI]
  • 20. Kang J, Cho JH, Suh CW, Lee DH, Oh HB, Sohn YH, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol. 2011; 90(2): 159-64[DOI][PubMed]
  • 21. Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol. 2008; 80(6): 960-6[DOI][PubMed]
  • 22. Nath A, Agarwal R, Malhotra P, Varma S. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J. 2010; 40(9): 633-41[DOI][PubMed]
  • 23. Sitnik R, Pinho JR, Bertolini DA, Bernardini AP, Da Silva LC, Carrilho FJ. Hepatitis B virus genotypes and precore and core mutants in Brazilian patients. J Clin Microbiol. 2004; 42(6): 2455-60[DOI][PubMed]
  • 24. Fernandez E, Rodrigo L, Garcia S, Riestra S, Blanco C. Hepatitis B surface antigen detection using pooled sera. A cost-benefit analysis. Rev Esp Enferm Dig. 2006; 98(2): 112-21[PubMed]
  • 25. de Souza MM, Barbosa MA, Borges AM, Daher RR, Martins RM, Cardoso D. [Seroprevalence of hepatitis B virus infection in patients with mental problems]. Rev Bras Psiquiatr. 2004; 26(1): 35-8[PubMed]
  • 26. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol. 1987; 61(10): 3030-4[PubMed]
  • 27. Hui CK, Sun J, Au WY, Lie AK, Yueng YH, Zhang HY, et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol. 2005; 42(6): 813-9[DOI][PubMed]
  • 28. Chen MH, Hsiao LT, Chiou TJ, Liu JH, Gau JP, Teng HW, et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol. 2008; 87(6): 475-80[DOI][PubMed]
  • 29. Marcucci F, Spada E, Mele A, Caserta CA, Pulsoni A. The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res. 2012; 2(1): 18-28[PubMed]
  • 30. Eftekhari Y, Kazemi Arababadi M, Hakimi H, Rezazadeh Zarandi E. Common HBV genotype in southeastern Iranian patients. Arch Iran Med. 2010; 13(2): 147-9[PubMed]
  • 31. Anderson LA, Engels EA. Hepatitis C virus infection and non-Hodgkin lymphoma: interesting association or causal relationship? Int J Cancer. 2008; 122(8)[DOI][PubMed]
  • 32. Ozguroglu M, Bilici A, Turna H, Serdengecti S. Reactivation of Hepatitis B Virus Infection with Cytotoxic Therapy in Non-Hodgkin's Lymphoma. Med Oncol. 2004; 21(1): 67-72[DOI]
  • 33. Kim JS, Hahn JS, Park SY, Kim Y, Park IH, Lee CK, et al. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma. Yonsei Med J. 2007; 48(1): 78-89[PubMed]
  • 34. Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, et al. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma. Ann Hematol. 2004; 83(1): 58-60[DOI][PubMed]
  • 35. Jadali Z. Hepatitis C virus cryoglobulinemia and non-hodgkin lymphoma. Hepat Mon. 2012; 12(2): 85-91[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments